Avricore Health (AVCRF) Equity Average (2016 - 2025)

Avricore Health has disclosed Equity Average across 8 years of filings, most recently posting $1.1 million for Q3 2025.

• In Q3 2025, Equity Average fell 39.54% year-over-year to $1.1 million; the TTM figure through Sep 2025 stood at $1.1 million (down 39.54% YoY), while the FY2025 annual figure was $1.1 million, changed N/A from the prior year.
• Equity Average eased to $1.1 million in Q3 2025, from $1.3 million in the prior quarter.
• Over the last five years, Equity Average for AVCRF reached as high as $1.7 million in Q3 2024 and fell as low as $1.1 million in Q3 2025.
• The 4-year median for Equity Average is $1.4 million (2023), against an average of $1.5 million.
• Annual changes were most pronounced in 2024 — Equity Average surged 30.28% — and 2025, when it tumbled 39.54%.
• A 4-year view of Equity Average shows it stood at $1.4 million in 2022, then climbed by 1.21% to $1.4 million in 2023, then gained by 14.51% to $1.6 million in 2024, then slumped by 34.74% to $1.1 million in 2025.
• According to Business Quant data, Equity Average over the past three periods registered $1.1 million, $1.3 million, and $1.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.